Doctors Brochures
If you do not currently have Acrobat Reader installed on your computer, please download the free Acrobat Reader here.
Click on the images to download the brochures in PDF format
 |
Irinotecan Toxicity: In studies, patients treated with irinotecan who are homozygous UGT1A1*28 have been found to be at an increased risk of neutropenia and other toxicities related to increased blood levels.> |  |
Are you
on Warfarin?: Warfarin is an anticoagulant that is used to prevent blood clots. This test enables the doctor to predict what dose is right for you. |
 |
 |
Pharmacogenomics: Explains how an individuals genetic make-up explains the way they respond to medication. Healthscope Advanced Pathology in conjunction with GenesFX Health now offers a premium pharmacogenomic service known as DNAdose-Personalised Prescribing. DNAdose now offers expert interpretation via a “Personalised Drug-specific Report”, these reports are prepared in conjunction with a clinical geneticist, a pharmacist and a clinical pharmacologist. | |
 |
BRAF Testing: When BRAF is activated by mutation, it leads to uncontrolled cell growth and division, resulting in cancer. |  |
Pharmacogenomic Testing to Aid Warfarin Dosing: Predicting the does of warfarin therapy for an individual patient can be made easier by genotyping. |
| [Back to Top] | |||
 |
 |
Breast Cancer and tamoxifen: A large proportion of women with breast cancer may not receive the full medical benefit from taking tamoxifen, because of their unique genetic make-up. Identification of their CYP2D6 genotype may identify those who are less likely to benefit from tamoxifen therapy. |
|
 |
 |
Tumour Gene Mutation Testing: With the increasing use of tyrosine kinase inhibitors for various cancer types, the accurate detection of specific gene mutations within a tumour is now important to enable clinicians to select the right treatment with the best response outcomes. | |
 |
TPMT PredictAR enables clinicians to develop a thiopurine treatment strategy that minimises the risk of potentially life-threatening haematopoietic toxicity. |  |
KRAS Testing: When KRAS is ‘turned on’ by a mutation, it leads to uncontrolled cell growth and division, resulting in cancer. |
 |
Clopidogrel PredictAR: Pharmacogenetic testing to aid in assessing the efficacy of clopidogrel, a widely used anti-platelet agent. |  |
Options for Oncotype DX sample preparation: Options for sending tumour samples or slides for Oncotype DX testing. |
 |
EGFR Testing: The Epidermal Growth Factor Receptor (EGFR) is one of four receptors in the HER (Human Epidermal Growth Factor Receptor) signalling pathway. |  |
Cytogenetics Service: A Complete Range of Cytogenetic Services for Pre Natal Diagnosis and Post Natal Analysis. |
| [Back to Top] | |||